Promoting evidence-based management of anemia in cancer patients: Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines

Critical Reviews in Oncology/Hematology

Volumn 65, Issue 1, 2008, Pages 32-42

  Aapro, Matti ^a   Van Erps, Joanna ^b   MacDonald, Karen ^c   Soubeyran, Pierre ^d,e   Turner, Matthew ^f   Muenzberg, Michael ^g   Dunlop, Robert ^h   Warrinnier, Hans ⁱ   Abraham, Ivo ^c,j  

^a CLINIQUE DE GENOLIER   (Switzerland)

^b Algemeen Stedelijk Ziekenhuis   (Belgium)

^c Matrix45 ^*  (United States)

^d INSTITUT BERGONIÉ   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f ROCHE PRODUCTS LTD   (United Kingdom)

^g F HOFFMANN LA ROCHE LTD   (Switzerland)

^h InferMed Ltd   (United Kingdom)

ⁱ Roche   (Belgium)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Anemia; Cancer; Decision support systems; Erythropoietic proteins; Treatment guidelines; Validation

Indexed keywords

ERYTHROPOIETIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ALGORITHM; ANEMIA; CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER AIDED DESIGN; COMPUTER PROGRAM; CONCURRENT VALIDITY; CONTENT VALIDITY; CORRELATION COEFFICIENT; DESCRIPTIVE RESEARCH; DIAGNOSTIC ACCURACY; DISCRIMINANT VALIDITY; EVIDENCE BASED MEDICINE; HUMAN; HYBRID COMPUTER; PATIENT CARE; PATIENT SELECTION; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RELIABILITY; RESPOND; RETROSPECTIVE STUDY; REVIEW; VALIDATION PROCESS; VALIDATION STUDY;

EID: 36849074240     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.05.002     Document Type: Review

References (23)

1. Groopman J.E., and Itri L.M. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91 (1999) 1616-1634
2. Ludwig H., Van Belle S., Barrett-Lee P., et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients. Eur J Cancer 40 (2004) 2293-2306
3. Weiss G., and Goodnough L.T. Anemia of chronic disease. New Engl J Med 352 (2005) 1011-1023
4. Blohmer J.U., Dunst J., Harrison L., et al. Cancer-related anemia: biological findings, clinical implications and impact on quality of life. Oncology 68 Suppl. 1 (2005) 12-21
5. Caro J.J., Salas M., Ward A., and Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91 (2001) 2214-2221
6. Nissenson A.R., Goodnough L.T., and Dubois R.W. Anemia: not just an innocent bystander?. Arch Intern Med 163 (2003) 1400-1404
7. Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 25 (1998) 43-46
8. Rizzo J.D., Lichtin A.E., Woolf S.H., et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 20 (2002) 4083-4107
9. Bokemeyer C., Aapro M.S., Courdi A., et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 40 (2004) 2201-2216
10. Bokemeyer C., Aapro M.S., Courdi A., et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 43 (2007) 258-270
11. Eddy D.M. Evidence-based medicine: a unified approach. Health Aff 24 (2005) 9-17
12. Timmermans S., and Mauck A. The promises and pitfalls of evidence-based medicine. Health Aff 24 (2005) 18-28
13. Halstenson C.E., Macres M., Katz S.A., et al. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin Pharmacol Ther 50 (1991) 702-712
14. Overbay D.K., and Manley H.J. Darbepoetin-alpha: a review of the literature. Pharmacotherapy 22 (2002) 889-897
15. Shiffman R.N., Brandt C.A., Liaw Y., and Corb G.J. A design model for computer-based guideline implementation based on information management services. J Am Med Inform Assoc 6 (1999) 99-103
16. Sim I., Gorman P., Greenes R.A., et al. Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc 8 (2001) 527-534
17. Bates D.W., Kuperman G.J., Wang S., et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 10 (2003) 523-530
18. Berner E.S. Clinical decision-support systems: theory and practice. 2nd ed. (1998), Springer-Verlag, New York
19. Musen M.A., Shahar Y., and Shortliffe E.H. Clinical decision support systems. In: Shortliffe E.H., and Cimino J.J. (Eds). Biomedical informatics: computer applications in health care and biomedicine. 3rd ed. (2006), Springer Verlag, New York
20. Kawamoto K., Houlihan C.A., Balas E.A., and Lobach D.F. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. Br Med J 330 (2005) 775-782
21. Nunnally J.C., and Bernstein I. Psychometric theory. 3rd ed. (1994), McGraw-Hill, New York
22. Park H.M., and Jung H.W. Evaluating interrater agreement with intraclass correlation coefficient in SPICE-based software process assessment. IEEE proceedings, third international conference on quality software (2003), IEEE, Washington, DC
23. Aapro M., Abraham I., MacDonald K., et al. Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision-support system for supportive cancer care. Support Care Cancer 15 (2007) 1325-1329